Vijay Pande (L) and Vineeta Agarwala
December 9, 2024 01:49 PM EST
People
Startups
AI

Ex­clu­sive: Vi­jay Pande hands a16z biotech lead­er­ship to Vi­nee­ta Agar­wala, moves to AI role

Max Bayer

Pharma Reporter

Kyle LaHucik

Senior Reporter

The biotech and life sci­ences team at a16z is get­ting a new leader, as found­ing in­vestor Vi­jay Pande moves in­to a role fo­cused on ar­ti­fi­cial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

US with­draw­al from WHO could jeop­ar­dize in­for­ma­tion shar­ing

Chi­na's biotech boom is threat­en­ing US drug­mak­er­s' dom­i­nance

Sanofi says no sup­ply in­ter­rup­tions af­ter land­ing FDA warn­ing let­ter for US site

Re­newed mifepri­s­tone fight will be ear­ly test of Trump’s abor­tion stance in his sec­ond term

J&J's Spra­va­to wins ex­pand­ed la­bel for de­pres­sion as sin­gu­lar treat­ment

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times